Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATH Extension Study: Long-term Safety and Efficacy of Hizentra in CIDP
NCT02027701Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Jul 2014
- Primary completion
- Jul 2017
- Modality
- Biologic
- Countries
- 11
01
Overview
A Phase 3 trial of IgPro10 in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by CSL Limited. Started Jul 2014; status: completed.
02
Drugs
IgPro10
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NCT02027701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027701.